Investment Opportunities

Zhittya is contracting various funds to verify if FGF-1 can reverse: Type-2 Diabetes, Chronic Wounds, and/or Heart Disease. Investors interested in funding the study have the potential profit returns of:

• 10x return from a 50% royalty on all FGF-1 revenues for the particular medical indication OR

• 2x their investment (at investor put option) after 48 months, if the investor is not happy
  
  Minimum: $25,000.

Submit the form for more details. This is informational only—not an offer to invest.

Disclaimer: This is not an offer to sell, nor a solicitation of an offer to buy, any securities. Any potential investment opportunities will be provided only to qualified, accredited investors in compliance with SEC regulations, including Rule 506(c) of Regulation D where applicable. Investments involve significant risk, including the potential loss of principal. Past performance is not indicative of future results. For details, accredited investors may request a private placement memorandum upon qualification. Zhittya Genesis Medicine makes no representations or warranties regarding returns or outcomes.